While the vaccination campaign has already started a few weeks in some Chinese regions, the government has ordered a large dose of vaccines in order to massively vaccinate the population as quickly as possible.
The different Chinese regions are preparing
Many epidemic foci have reappeared especially in Shanghai, Qingdao, Urumqi, Tianjin and Hong Kong, China has decided to launch a massive vaccination campaign even though no laboratory has yet validated phase III of their respective vaccines. Beijing has reportedly already received tens of thousands of doses and plans to produce 610 million doses by the end of the year and up to a billion next year.
All Chinese regions are reportedly currently ordering from laboratories for emergency use to conduct massive screening. The Associated Press reported that Anhui province and the Sichuan region, which has a population of 85 million, have already purchased vaccines while the government of Jiangsu, with a population of 79 million, has asked for an opinion purchase and wants to quickly acquire vaccines from Chinese laboratories Sinovac and Sinopharm.
Chinese laboratories in a race for vaccines
Three laboratories are currently competing for anti-covid vaccines: CanSino, Sinovac Biotech and Sinopharm. These Chinese laboratories have not yet published their results regarding the efficacy of the vaccines for the phase III trials. ” Laboratories speed up final tests Chinese Minister of Affairs Wang Yi said. According to the official press, Sinipharm is the only pharmaceutical group to have requested marketing in China. The company has also revealed that more than a million people have already been vaccinated, such as medical staff, airline employees or people going abroad. About 85% of Chinese people trust vaccines and will get vaccinated.
In addition, Sinovac has already shipped many doses of vaccines to Jakarta (1.2 million), Brazil (more than one million). A delivery of 1.8 million vaccines is expected within a week for Indonesia. Turkey has “pre-ordered 50 million doses” of Chinese vaccines, according to the Wall Street Journal.
